Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004268
Filing Date
2025-06-13
Accepted
2025-06-13 16:22:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4599
  Complete submission text file 0001950047-25-004268.txt   6085
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KAPLAN GILLA (Reporting) CIK: 0001247024 (see all company filings)

Type: 144

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Subject) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40800 | Film No.: 251046912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)